EUVIMEDEUVIMED entdecken
Open Access

Mechanism, Structure, and Inhibition of O-GlcNAc Processing Enzymes

Tracey M Gloster, David J Vocadlo

Current Signal Transduction Therapy · 01.01.2010 · 5 (1) · 74-91

DOI: 10.2174/157436210790226537 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Current Signal Transduction Therapy, erschienen am 01.01.2010. Verfasst von Tracey M Gloster und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Simon Fraser University, 8888 University Drive, Burnaby, BC, V5A 1S6, Canada. Die Arbeit wurde bisher 59-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Wellcome Trust.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The post-translational modification of nucleocytoplasmic proteins with O-linked 2-acetamido-2-deoxy-d-glucopyranose (O-GlcNAc) is a topic of considerable interest and attracts a great deal of research effort. O-GlcNAcylation is a dynamic process which can occur multiple times over the lifetime of a protein, sometimes in a reciprocal relationship with phosphorylation. Several hundred proteins, which are involved in a diverse range of cellular processes, have been identified as being modified with the monosaccharide. The control of the O-GlcNAc modification state on different protein targets appears to be important in the aetiology of a number of diseases, including type II diabetes, neurodegenerative diseases and cancer. Two enzymes are responsible for the addition and removal of the O-GlcNAc modification: uridine diphospho-N-acetylglucosamine:polypeptide beta-N-acetylglucosaminyltransferase (OGT) and O-GlcNAcase (OGA), respectively. Over the past decade the volume of information known about these two enzymes has increased significantly. In particular, mechanistic studies of OGA, in conjunction with structural studies of bacterial homologues of OGA have stimulated the design of inhibitors and offered a rationale for the binding of certain potent and selective inhibitors. Mechanistic information about OGT lags a little way behind OGA, but the recent deduction of the structure of an OGT bacterial homologue should now drive these studies forward.

Autor:innen und Institutionen

  • Department of Chemistry, Simon Fraser University, 8888 University Drive, Burnaby, BC, V5A 1S6, Canada.

Förderung

  • Wellcome Trust

Zitieren

APA

Gloster, T. M., & Vocadlo, D. J. (2010). Mechanism, Structure, and Inhibition of O-GlcNAc Processing Enzymes. Current Signal Transduction Therapy, 5(1), 74-91. https://doi.org/10.2174/157436210790226537

Vancouver

Gloster TM, Vocadlo DJ. Mechanism, Structure, and Inhibition of O-GlcNAc Processing Enzymes. Current Signal Transduction Therapy. 2010;5(1):74-91. doi:10.2174/157436210790226537

BibTeX
@article{Gloster2010,
  author = {Gloster, Tracey M and Vocadlo, David J},
  title = {Mechanism, Structure, and Inhibition of O-GlcNAc Processing Enzymes},
  journal = {Current Signal Transduction Therapy},
  year = {2010},
  volume = {5},
  number = {1},
  pages = {74--91},
  doi = {10.2174/157436210790226537}
}
Kostenlos starten →